Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects With Non-Small Cell Lung Cancer (NSCLC)
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The primary objective of this Phase II study is to assess the safety, pharmacokinetics and
effectiveness of ABT-510 in combination with standard carboplatin/paclitaxel chemotherapy in
subjects with stage IIIb or IV NSCLC.